Susquehanna International Group, LLP Caribou Biosciences, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$1.62 - $5.05 $85,536 - $266,640	-52,800 Reduced 73.13%	19,400 $31,000
Q1 2024 May 07, 2024	BUY	$4.82 - $8.26 $205,332 - $351,876	42,600 Added 143.92%	72,200 $371,000
Q4 2023 Feb 14, 2024	SELL	$3.58 - $6.25 $122,794 - $214,375	-34,300 Reduced 53.68%	29,600 $169,000
Q3 2023 Nov 14, 2023	BUY	$4.08 - $8.14 $260,712 - $520,146	63,900 New	63,900 $305,000
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $35,244 - $84,414	6,600 Added 24.54%	33,500 $353,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $103M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.